Literature DB >> 18482815

Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals.

Kwan Soo Ko1, Mi Young Lee, Jae-Hoon Song, Hyuck Lee, Dong Sik Jung, Sook-In Jung, Shin-Woo Kim, Hyun-Ha Chang, Joon-Sup Yeom, Yeon-Sook Kim, Hyun Kyun Ki, Doo-Ryeon Chung, Ki Tae Kwon, Kyong Ran Peck, Nam Yong Lee.   

Abstract

Prevalence and characteristics of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in Korean hospitals were assessed. A total of 1484 clinical Enterobacteriaceae isolates were collected from 8 tertiary-care hospitals in various regions of Korea over a 3-month period (June to August) in 2005. Among 546 Klebsiella pneumoniae isolates, 123 isolates (22.4%) showed ESBL-producing activity, and 47 (10.2%) of 460 isolates of Escherichia coli were ESBL producers. Of the Enterobacter cloacae isolates, 16.2% (17/105) evidenced ESBL-producing activity. The most prevalent ESBLs were SHV-12 and CTX-M-14 in K. pneumoniae and E. coli, respectively. In E. cloacae, SHV-12 was also the most prevalent. Prevalence of ESBL production differed among the specimens. Although the K. pneumoniae isolates from urine and aspirates evidenced high ESBL production rates (35.4% and 57.1%, respectively), those from sputum, blood, and pus showed relatively low ESBL production rates (17.0%, 14.8%, and 5.3%, respectively). However, E. coli isolates obtained from sputum showed significantly higher ESBL production rates (37.5%) than were seen in samples obtained from other sources, but those obtained from urine showed lower ESBL production rates (8.3%). These significant differences in ESBL-producing K. pneumoniae and E. coli isolates among the isolated specimens should be examined further, with an eye toward the implications of this research in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482815     DOI: 10.1016/j.diagmicrobio.2008.03.005

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  17 in total

1.  [Multiresistant bacteria in ophthalmology].

Authors:  T Ness
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

2.  Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in Korean community and hospital settings.

Authors:  Y J Ko; H-W Moon; M Hur; C-M Park; S E Cho; Y-M Yun
Journal:  Infection       Date:  2012-06-22       Impact factor: 3.553

3.  Clinical significance of infections caused by plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamase-producing Escherichia coli.

Authors:  H S Cheong; K S Ko; C-I Kang; D R Chung; K R Peck; J-H Song
Journal:  Infection       Date:  2012-09-27       Impact factor: 3.553

4.  Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010-2011.

Authors:  Dong Sup Lee; Hyun-Sop Choe; Sung Jong Lee; Woong Jin Bae; Hyeong Jun Cho; Byung Il Yoon; Yong-Hyun Cho; Chang Hee Han; Hoon Jang; Su Bum Park; Won Jin Cho; Seung-Ju Lee
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

5.  An Improved Extended-Spectrum-β-Lactamase Detection Test Utilizing Aztreonam plus Clavulanate.

Authors:  Gina K Thomson; Maaz Ayaz; Kelli Lutes; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

6.  Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain.

Authors:  Aránzazu Valverde; Rafael Cantón; M Pilar Garcillán-Barcia; Angela Novais; Juan Carlos Galán; Andrés Alvarado; Fernando de la Cruz; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

7.  Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates.

Authors:  Trent G Towne; James S Lewis; Monica Herrera; Brian Wickes; James H Jorgensen
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

8.  Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.

Authors:  Stephen P Hawser; Samuel K Bouchillon; Daryl J Hoban; Robert E Badal; Po-Ren Hsueh; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

9.  Association of antibiotic resistance with SHV-12 extended-spectrum β-lactamase in Enterobacter cloacae.

Authors:  Jun Liu; Guo-Ming Li; Li-Yao Lin; Xia-Lei Wu; Shao-Long Huang; Yong Zhou; Zu-Guo Zhao
Journal:  Exp Ther Med       Date:  2015-11-10       Impact factor: 2.447

10.  Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.

Authors:  Sun Hee Park; Ji-Hyun Byun; Su-Mi Choi; Dong-Gun Lee; Si-Hyun Kim; Jae-Cheol Kwon; Chulmin Park; Jung-Hyun Choi; Jin-Hong Yoo
Journal:  BMC Infect Dis       Date:  2012-06-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.